Skip to main content
Erschienen in: Diagnostic Pathology 1/2016

Open Access 01.12.2016 | Case Report

Massive ovarian oedema: a misleading clinical entity

verfasst von: Nikolaos Machairiotis, Aikaterini Stylianaki, Paraskevi Kouroutou, Polixeni Sarli, Nikolaos Konstantinos Alexiou, Elias Efthymiou, Athanasios Maras, Nikolaos Georgios Alexiou, Spyridon Evaggelos Nikolaou, Nikolaos Courcoutsakis, Eleni Papakonstantinou, Paul Zarogoulidis, Nikolaos Barbetakis, Dimitrios Paliouras, Apostolos Gogakos, Christodoulos Machairiotis

Erschienen in: Diagnostic Pathology | Ausgabe 1/2016

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Massive ovarian oedema is a rare non-neoplastic clinicopathologic entity has a higher incidence in women during their second and third life decade. The oedema can be presented in one or both ovaries as a result of partial intermittent torsion of the ovarian pedicle that interferes to the venal and lymphatic drainage of the ovary.

Case presentation

We present a clinical case of a 16 year old with massive ovarian oedema and we performed a review of the literature. The pathophysiology of this entity is very complex. We tried to perform a complete review of the literature and focus on the complexity of this entity as far as its pathophysiological backround is concerned and as far as its clinical presentation is concerned.

Conclusions

In conclusion, massive ovarian oedema is a rare, multi disease mimicking clinical entity, with an acute or progressive clinical presentation. It has also to be a part of our differential diagnosis in cases of acute abdominal pain and we have to try to treat her conservatively, in order to preserve fertility.
Hinweise

Competing interests

The authors declare that they have no competing interests

Authors’ contributions

All authors contributed equally. All authors read and approved the final manuscript.
Abkürzungen
LH
luteinizing hormone
VEGF
vascular endothelial growth factor
VEGFR2
vascular endothelial growth factor receptor
fsh
follicle stimulating hormone

Background

Massive ovarian oedema is a rare clinical entity, which is benign and has a higher incidence in women during their second and third life decade. This lesion was first described in 1967 [1] as a “tumour like” enlargement of the ovary due to oedema fluid. The oedema can be presented in one or both ovaries as a result of partial intermittent torsion of the ovarian pedicle that interferes to the venal and lymphatic drainage of the ovary [2]. The fact that the ovarian torsion is incomplete explains the fact that an ovarian cell necrosis is not caused; the effect of this lymphatic drainage obstruction is the enlargement of the ovary, which can be presented to the patient as a solid, adnexal mass. The clinical presentation of ovarian oedema can be either acute or progressive depending on the rapidity of the torsion. In other words, if the torsion is acute; the symptomatology is acute abdominal pain and could be mimicking an acute abdomen. If it presents in the right ovary and it’s expressed with pain in the right lower abdominal quadrant, has to be differential diagnosed from appendicitis. If the torsion is gradual then a stromal luteinization is provoked and the patient is often virilized. Menstrual irregularities, precocious puberty or even Meigs syndrome can be the clinical manifestations of this entity [3] (Table 1).
Table 1
Clinical findings upon admission and discharge
Clinical findings upon admission
Clinical findings upon discharge
Persistent abdominal pain in her right lower abdominal quadrant
Abdomen without any symptomatology
Palpable abdominal mass extending from the fossa iliaca to the liver
Abdomen soft, without peritonaism in palpation
CA 125 marker of 57,9
 
CT cystic lesion 23 × 15 cm located in the right oblique abdominal area

Case presentation

A 16-year-old patient was admitted in our emergency department with persistent abdominal pain in her right lower abdominal quadrant. The patient claimed that the pain was colic like, persistent and gradually advancing the last 2 months. Her medical history was free, her menarche was in the age of 13 years and her menstrual cycle had a periodicity of 28 days. The clinical examination revealed a palpable abdominal mass extending from the fossa iliaca to the liver. The patient was hemodynamic stable. After two doses of intravenous paracetamol the pain was alleviated. We performed a radiologic and laboratory control; our imaging control included an Ultrasound of the lower abdomen and a Ct Scan of the upper and lower abdomen. An intravaginal ultrasound control could not be performed because the patient was still virgin. The CT scan revealed a cystic lesion 23x15cm located in the right oblique abdominal area, from the liver to the minor pelvis, which is causing pressure to the right kidney and the bladder and a small fluid collection in the Douglas region. (Fig. 1) This finding combined with the laboratory values, which showed an elevated CA 125 marker of 57,9 and a normal function of the hepatobilliary and the urinary system, led us to make a decision to perform a laparotomy. We performed a subumbilical incision of the abdomen. The ovary was identified, it was very swollen and there was fluid in the rightovarian pedicle. This specimen was taken for cytologic examination, which was negative for malignancy. An incision of the ovarian mass followed in order to make it possible to remove the ovary from the abdomen. The structure was bulky without any fluid and the excision was very difficult. Intraoperatively, after performing a light traction of the ovary a triple partial torsion of the ovarian pedicle was seen, nevertheless, there were no signs of ischemia or necrosis of the ovary. After careful preparation of the ovary and the pedicle we performed the excision and the specimen (excised ovary) was sent as a frozen section material for histopathologic examination (Fig. 2). The result was negative for malignancy and was compatible with normal ovarian tissue. The left ovary had a normal anatomy without any evidence of pathology or dysfunction. Macroscopically, the excided ovary was a kidney-like, very oedematous structure 23x14x5 cm. There was no sign of necrosis or hemorrhage, but there were many cystic lesions on the upper surface of the ovary, with a maximum diameter of 1.5 cm and a serous content (Fig. 3). Afterwards we performed an appendectomy. The patient recovered very fast postoperatively, without any pain and symptoms. The pathologic examination revealed a stroma oedema with presence of many fibroblast and collagen fibre, cystic ovarian folicules with lutenization in the periphery of the ovary without any stromal changes (Fig. 4). In the appendix many parasitic worms were present of the type of Enterobius Vermicularis.

Discussion

Massive ovarian oedema is a tumor-mimicking condition occurring in young women [1]. It is often considered to be the result of complete torsion of the ovary to the extent that it interferes with venous and lymphatic drainage but is insufficient to cause necrosis [2, 4]. In addition to this mechanism, there is the pathophysiological mechanism of the partial ovarian torsion. This is based to the histopathological evidence of a hematoma [4]. There are many authors suggesting that partial torsion is a likely explanation for this perplexing disorder [4] and it considered to be a variant of polycystic ovary syndrome [5]. As a result of the enlargement of the ovary, the intrabdominal pressure rises, causing a pressure phenomenon in the nearby area and the patient usually presents with adnexal mass. The character of the symptomatology, acute pain or profound diffuse pain depends on the character of the torsion. In case of an acute torsion, the abdominal pain with the clinical presentation of an acute abdomen is the main symptom. In most of the cases described in the literature there are menstrual irregularities, infertility and abdominal distension [6]. Massive ovarian oedema is considered to be the result of ovarian lymphatic dysfunction. The question that rises is; how could the lymphatic dysfunction cause this kind of symptomatology? The answer is hidden in the unique capacity of the ovary to remodel its tissue structure and vascular network continuously and under a strictly controlled process.
The lymphatic vessels have a special morphology without a structural basement membrane and an overlapping layer of vascular endothelial cells. The functionality of these cells is controlled from the Vascular Endothelial Growth Factor (VEGF) and its receptor (VEGFR2) [7]. There are scientific studies showing that the inhibition of VEGFR2 prohibits the normal luteinization process [8, 9]. The ovarian lymph contains among others; hormones including progesterone, estradiol and inhibin that are transferred back to the ovarian arteries via retrograde transfer and then they promote the feedback in the hormonal regulation of the ovary [10, 11]. Given the mechanism mentioned above, the lymphatic dysfunction prohibits the normal luteinization of the ovary and causes hormonal problems. This is the mechanism that is thought to be responsible for the formation of primary ovarian oedema [12]. On the other hand massive ovarian oedema has been correlated in the literature with retroperitoneal lymphoma, metastatic carcinoma, polycystic ovary syndrome, metastatic-cervical carcinoma [12]. In those cases, massive ovarian oedema is characterized “secondary massive ovarian oedema” as a result of lymphatic vascular blockage. In patients under hormonal therapy and especially in therapy with clomiphene citrate the increase of LH and FSH cause changes in the lymphatic vasculature [13]. The menstrual irregularities can be a result of low serum levels of gonadotropins, because of an autonomous ovarian hormone production [14, 15]. This hormone production is a result of stromal luteinization according to Chervenak et al. [14]. On the other hand, Kalstone et al. suggested that the luteinization might be caused because of the mechanical stimulus of increasing quantity by oedema fluid which is stretching the stroma [1, 15]. Another theory for the formation of the oedema and the abnormal hormone production is the impact of insulin-like growth factor, epidermal growth factor or cytokines in the ovarian stroma cells [4]. There are very few literature references on massive ovarian oedema as a permeation of the ovarian lymphatics by metastatic carcinoma [16, 17]. The mechanisms mentioned above explain why masculanization and precocious puberty are common features among women suffering from massive ovarian oedema. The most interesting part of this clinical entity is the histopathological findings, which set the diagnosis. The ovarian stromal cells which are separated by copious oedema fluid with presence of atretic follicles without any involvement of the tunica albuginea and the superficial cortical zone are characteristically uninvolved [2]. A thin rim of compressed cortical stroma is recognized at the periphery of the mass. Necrosis and hemorrhage are unusual. Additionally, the presence of focal stream luteinization has also been described. The oedema of the stroma is thought to provoke the activation of fibroblasts and myofibroblasts in the stroma as a reaction to the oedema [18]. The therapeutic approach varies. The great majority of cases are unilateral and the most common treatment is unilateral salpingo-oopherectomy [19]. Frozen section is an option for preventing unnecessary catastrophic reproductive outcomes, on the other hand we have always to keep in mind the risk of recurrence [20]. Another option is wedge resection, which involves the removal of a minimum 30 % of the ovarian volume. This is performed in order to exclude secondary massive ovarian oedema. The possibility of postoperative adhesions is an argument to the complete removal of the ovary, because it provokes fertility issues [6, 21]. Laparoscopy can also be a therapeutic option for massive ovarian oedema as it combines diagnostics and therapy [22, 23]. Massive ovarian oedema is a result of the symptomatology and the intraoperative findings, as these lesions are often mistaken for primary ovarian neoplasms at laparotomy. Taking under consideration the age of the patients presenting with this entity, the preservation of fertility should be our first thought and conservative treatment must be the rule [19].

Conclusion

Massive ovarian oedema is a rare, multi disease mimicking clinical entity, with an acute or progressive clinical presentation. It has also to be a part of our differential diagnosis in cases of acute abdominal pain and we have to try to treat it conservatively, in order to preserve fertility.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests

Authors’ contributions

All authors contributed equally. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Kalstone CE, Jaffe RB, Abell MR. Massive edema of the ovary simulating fibroma. Obstet Gynecol. 1969;34(4):564–71.PubMed Kalstone CE, Jaffe RB, Abell MR. Massive edema of the ovary simulating fibroma. Obstet Gynecol. 1969;34(4):564–71.PubMed
2.
Zurück zum Zitat Roth LM, Deaton RL, Sternberg WH. Massive ovarian edema. A clinicopathologic study of five cases including ultrastructural observations and review of the literature. Am J Surg Pathol. 1979;3(1):11–21.CrossRefPubMed Roth LM, Deaton RL, Sternberg WH. Massive ovarian edema. A clinicopathologic study of five cases including ultrastructural observations and review of the literature. Am J Surg Pathol. 1979;3(1):11–21.CrossRefPubMed
3.
Zurück zum Zitat Nogales FF, Martin-Sances L, Mendoza-Garcia E, Salamanca A, Gonzalez-Nunez MA, Pardo Mindan FJ. Massive ovarian oedema. Histopathology. 1996;28(3):229–34.CrossRefPubMed Nogales FF, Martin-Sances L, Mendoza-Garcia E, Salamanca A, Gonzalez-Nunez MA, Pardo Mindan FJ. Massive ovarian oedema. Histopathology. 1996;28(3):229–34.CrossRefPubMed
5.
Zurück zum Zitat Roth LM. Massive ovarian edema with stromal luteinization: a newly recognized virilizing syndrome apparently related to partial torsion of the mesovarium. Am J Clin Pathol. 1971;55(6):757–60.PubMed Roth LM. Massive ovarian edema with stromal luteinization: a newly recognized virilizing syndrome apparently related to partial torsion of the mesovarium. Am J Clin Pathol. 1971;55(6):757–60.PubMed
6.
Zurück zum Zitat Daboubi MK, Khreisat B. Massive ovarian oedema: literature review and case presentation. East Mediterr Health J. 2008;14(4):972–7.PubMed Daboubi MK, Khreisat B. Massive ovarian oedema: literature review and case presentation. East Mediterr Health J. 2008;14(4):972–7.PubMed
7.
Zurück zum Zitat Taylor PD, Wilson H, Hillier SG, Wiegand SJ, Fraser HM. Effects of inhibition of vascular endothelial growth factor at time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset. Mol Hum Reprod. 2007;13(10):729–36. doi:10.1093/molehr/gam056.CrossRefPubMed Taylor PD, Wilson H, Hillier SG, Wiegand SJ, Fraser HM. Effects of inhibition of vascular endothelial growth factor at time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset. Mol Hum Reprod. 2007;13(10):729–36. doi:10.​1093/​molehr/​gam056.CrossRefPubMed
8.
Zurück zum Zitat Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med. 1998;4(3):336–40.CrossRefPubMed Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med. 1998;4(3):336–40.CrossRefPubMed
9.
Zurück zum Zitat Zimmermann RC, Hartman T, Kavic S, Pauli SA, Bohlen P, Sauer MV, et al. Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest. 2003;112(5):659–69. doi:10.1172/JCI18740.PubMedCentralCrossRefPubMed Zimmermann RC, Hartman T, Kavic S, Pauli SA, Bohlen P, Sauer MV, et al. Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest. 2003;112(5):659–69. doi:10.​1172/​JCI18740.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Findlay JK, Tsonis CG, Staples LD, Cahill RN. Inhibin secretion by the sheep ovary. J Reprod Fertil. 1986;76(2):751–61.CrossRefPubMed Findlay JK, Tsonis CG, Staples LD, Cahill RN. Inhibin secretion by the sheep ovary. J Reprod Fertil. 1986;76(2):751–61.CrossRefPubMed
11.
Zurück zum Zitat Stefanczyk-Krzymowska S, Krzymowski T, Wasowska B, Chlopek J. Retrograde transfer of ovarian steroid hormones to the ovary in the porcine periovarian vascular complex. Exp Physiol. 2002;87(3):361–71.CrossRefPubMed Stefanczyk-Krzymowska S, Krzymowski T, Wasowska B, Chlopek J. Retrograde transfer of ovarian steroid hormones to the ovary in the porcine periovarian vascular complex. Exp Physiol. 2002;87(3):361–71.CrossRefPubMed
13.
14.
Zurück zum Zitat Chervenak FA, Castadot MJ, Wiederman J, Sedlis A. Massive ovarian edema: review of world literature and report of two cases. Obstet Gynecol Surv. 1980;35(11):677–84.CrossRefPubMed Chervenak FA, Castadot MJ, Wiederman J, Sedlis A. Massive ovarian edema: review of world literature and report of two cases. Obstet Gynecol Surv. 1980;35(11):677–84.CrossRefPubMed
15.
Zurück zum Zitat Vasquez SB, Sotos JF, Kim MH. Massive edema of the ovary and virilization. Obstet Gynecol. 1982;59(6 Suppl):95S–9S.PubMed Vasquez SB, Sotos JF, Kim MH. Massive edema of the ovary and virilization. Obstet Gynecol. 1982;59(6 Suppl):95S–9S.PubMed
17.
Zurück zum Zitat Dalloul M, Sherer DM, Gorelick C, Serur E, Zinn H, Sanmugarajah J, et al. Transient bilateral ovarian enlargement associated with large retroperitoneal lymphoma. Ultrasound Obstet Gynecol. 2007;29(2):236–8. doi:10.1002/uog.3920.CrossRefPubMed Dalloul M, Sherer DM, Gorelick C, Serur E, Zinn H, Sanmugarajah J, et al. Transient bilateral ovarian enlargement associated with large retroperitoneal lymphoma. Ultrasound Obstet Gynecol. 2007;29(2):236–8. doi:10.​1002/​uog.​3920.CrossRefPubMed
18.
Zurück zum Zitat Kanumakala S, Warne GL, Stokes KB, Chan YF, Grover S. Massive ovarian edema causing early puberty. J Pediatr Endocrinol Metab. 2002;15(6):861–4.CrossRefPubMed Kanumakala S, Warne GL, Stokes KB, Chan YF, Grover S. Massive ovarian edema causing early puberty. J Pediatr Endocrinol Metab. 2002;15(6):861–4.CrossRefPubMed
19.
Zurück zum Zitat Mutijima E, Mokni M, Soua Ael H, Ziadi S, Mestiri S, Yacoubi MT, et al. Massive ovarian oedema. Rev Med Liege. 2004;59(9):522–4.PubMed Mutijima E, Mokni M, Soua Ael H, Ziadi S, Mestiri S, Yacoubi MT, et al. Massive ovarian oedema. Rev Med Liege. 2004;59(9):522–4.PubMed
20.
22.
Zurück zum Zitat Kocak M, Caliskan E, Haberal A. Laparoscopic conservation of the ovaries in cases with massive ovarian oedema. Gynecol Obstet Invest. 2002;53(2):129–32. doi:53009.CrossRefPubMed Kocak M, Caliskan E, Haberal A. Laparoscopic conservation of the ovaries in cases with massive ovarian oedema. Gynecol Obstet Invest. 2002;53(2):129–32. doi:53009.CrossRefPubMed
23.
Zurück zum Zitat Kallipolitis G, Sklia E, Milingos S, Michalas S. Laparoscopic treatment of massive ovarian edema. J Am Assoc Gynecol Laparosc. 1999;6(4):513–6.CrossRefPubMed Kallipolitis G, Sklia E, Milingos S, Michalas S. Laparoscopic treatment of massive ovarian edema. J Am Assoc Gynecol Laparosc. 1999;6(4):513–6.CrossRefPubMed
Metadaten
Titel
Massive ovarian oedema: a misleading clinical entity
verfasst von
Nikolaos Machairiotis
Aikaterini Stylianaki
Paraskevi Kouroutou
Polixeni Sarli
Nikolaos Konstantinos Alexiou
Elias Efthymiou
Athanasios Maras
Nikolaos Georgios Alexiou
Spyridon Evaggelos Nikolaou
Nikolaos Courcoutsakis
Eleni Papakonstantinou
Paul Zarogoulidis
Nikolaos Barbetakis
Dimitrios Paliouras
Apostolos Gogakos
Christodoulos Machairiotis
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
Diagnostic Pathology / Ausgabe 1/2016
Elektronische ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-016-0469-3

Weitere Artikel der Ausgabe 1/2016

Diagnostic Pathology 1/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie